Aug 2013 $14 M No. 4 $10 to $50 million 179
WaferGen Bio-systems, Inc.: Raise no. 4, Aug 2013 × Investors in this round 179 investors had bought by the notice of Sep 10, 2013: 179 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $14 M of $15 M offered; $1 M still to sell
Smallest investment taken $50,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,166,850
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Nevada People named in the notice Ivan Dean Trifunovich · Executive Officer, Director John Dean Harland · Executive Officer Alnoor Shivji · Director Joel Dean Kanter · Director Joseph Dean Pesce · Director Makoto Dean Kaneshiro · Director R. Dean Hautamaki · Director Robert Coradini · Director Scott Davidson · Director Timothy Dean Triche · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round National Securities Corporation (CRD 7569) · New York, New York Sold in AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, LA, MA, MD, MI, MN, MO, MS, ND, NH, NJ, NY, OH, OK, OR, PA, RI, SC, TX, UT, VA, WA, WI, WY Remarks in the notice On the amounts: “Minimum investment amount may be waived. Total offering amount may be increased by up to $2,250,000 to cover over-allotments, if any.”Signed by John Harland, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 10, 2013. Read the notice at the SEC .
equity, options SEC May 2011 $31 M No. 3 $10 to $50 million 22
WaferGen Bio-systems, Inc.: Raise no. 3, May 2011 × Investors in this round 22 investors had bought by the notice of Jun 1, 2011: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $31 M of $31 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,138,500
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Nevada People named in the notice Alnoor Shivji · Director, Executive Officer Donald Dean Huffman · Executive Officer Mona Dean Chadha · Executive Officer Joel Dean Kanter · Director Makoto Dean Kaneshiro · Director R. Dean Hautamaki · Director Robert Coradini · Director Robert J. Hariri · Director Timothy Dean Triche · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Madison Williams and Company (CRD 149530) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY Summer Street Research Partners (CRD 127142) · Boston, Massachusetts Sold in AZ, CA, GA, IL, MA, MD, MS, NY, WI Oppenheimer & Co. Inc. (CRD 249) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY Remarks in the notice On the use of proceeds: “Proceeds used for general working capital.”Signed by Alnoor Shivji, CEO, President & Chairman of the Board. Source: SEC Form D, newest notice filed Jun 1, 2011. Read the notice at the SEC .
equity, debt, options SEC Nov 2009 $5 M No. 2 $2 to $10 million 37
WaferGen Bio-systems, Inc.: Raise no. 2, Nov 2009 × Investors in this round 37 investors had bought by the notice of Feb 24, 2010: 37 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $25,000
What was sold equity, options or other rights to buy securities, other: Units consisting of one share of common stock and one warrant to purchase 25% of one share of common stock.
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $381,420
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Alnoor Shivji · Executive Officer, Director Raymond Dean Hautamaki · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Newport Coast Securities, Inc. (CRD 16944) · Irvine, Ca Sold in no state named Spencer Trask Ventures, Inc. (CRD 28373) · New York, Ny Sold in no state named Gilford Securities Incorporated (CRD 8076) · New York, Ny Sold in no state named Remarks in the notice On fees: “In addition to the dollar amount, sales commissions included warrants to purchase a total of 118,644 shares of stock at an exercise price of $2.50 per whole share.”Signed by Hector Brush, Principal Financial Officer. Source: SEC Form D, newest notice filed Feb 24, 2010. Read the notice at the SEC .
equity, options SEC May 2009 $6 M No. 1 $2 to $10 million 32
WaferGen Bio-systems, Inc.: Raise no. 1, May 2009 × Investors in this round 32 investors had bought by the notice of Sep 15, 2009: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for WaferGen Bio-systems, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken $10,000
What was sold equity, options or other rights to buy securities, other: Units consisting of one share of common stock and one warrant to purchase 30% of one share of common stock.
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $309,356
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Alnoor Shivji · Director, Executive Officer · Chief Executive Officer, President and Chairman of the Board Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Spencer Trask Ventures, Inc. (CRD 28373) · broker-dealer Spencer Trask Ventures, Inc. (CRD 28373) · New York, Ny Sold in no state named Signed by Alnoor Shivji, Chairman, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 15, 2009. Read the notice at the SEC .
equity, options SEC